| |
| |
|
| Insider
Information: |
Mcclure Natalie |
| Relationship: |
SVP, Product Development |
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
8,340 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$68,555 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,340 |
|
|
| Total
Value |
$68,555 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adamas Pharmaceuticals Inc |
ADMS |
SVP, Product Development |
2016-04-18 |
8,340 |
2014-12-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2016-04-18 |
4 |
AS |
$18.50 |
$666,000 |
D/D |
(36,000) |
8,340 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2016-04-18 |
4 |
OE |
$0.67 |
$37,746 |
D/D |
36,000 |
31,674 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2016-03-04 |
4 |
A |
$13.66 |
$102,450 |
D/D |
7,500 |
8,340 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-06-05 |
4 |
AS |
$18.95 |
$37,900 |
D/D |
(2,000) |
840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-06-05 |
4 |
OE |
$1.76 |
$3,510 |
D/D |
2,000 |
2,840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-05-05 |
4 |
AS |
$17.62 |
$35,240 |
D/D |
(2,000) |
840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-05-05 |
4 |
OE |
$1.76 |
$3,510 |
D/D |
2,000 |
2,840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-04-06 |
4 |
AS |
$17.44 |
$34,880 |
D/D |
(2,000) |
840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-04-06 |
4 |
OE |
$1.76 |
$3,510 |
D/D |
2,000 |
2,840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-03-05 |
4 |
AS |
$17.15 |
$34,300 |
D/D |
(2,000) |
840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-03-05 |
4 |
OE |
$1.76 |
$3,510 |
D/D |
2,000 |
2,840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-02-05 |
4 |
AS |
$16.87 |
$33,740 |
D/D |
(2,000) |
840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-02-05 |
4 |
OE |
$1.76 |
$3,510 |
D/D |
2,000 |
2,840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-01-05 |
4 |
AS |
$17.59 |
$35,180 |
D/D |
(2,000) |
840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2015-01-05 |
4 |
OE |
$1.76 |
$3,510 |
D/D |
2,000 |
2,840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2014-12-05 |
4 |
AS |
$14.01 |
$28,028 |
D/D |
(2,000) |
840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2014-12-05 |
4 |
OE |
$1.76 |
$3,510 |
D/D |
2,000 |
2,840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2014-12-01 |
4 |
AS |
$14.50 |
$290,000 |
D/D |
(20,000) |
840 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
SVP, Product Development |
• – – |
2014-12-01 |
4 |
OE |
$1.76 |
$35,100 |
D/D |
20,000 |
20,840 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
